News|Articles|October 2, 2004
- Pharmaceutical Technology-10-02-2004
- Volume 28
- Issue 10
Pharma Company Investment in Parenteral Manufacturing Capacity Picking Up
Author(s)Jim Miller
Big Pharma is ramping up capital spending in parenteral manufacturing at the same time that contract manufacturers are completing their own major investment programs.
Advertisement
Articles in this issue
over 21 years ago
A Novel Freeze Pelletization Technique for Preparing Matix Pelletsover 21 years ago
Aseptic Processing: A Review of Current Industry Practiceover 21 years ago
Can Inserts Be Improved?over 21 years ago
Drug Development Linked More Closely to Diagnosticsover 21 years ago
In The Spotlight-October 2004over 21 years ago
October 2004over 21 years ago
The High Price of SuccessNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Securing Radiopharma and GLP-1 Supply Chains Through 2026 M&A
3
Halo Pharma Becomes Dedicated North American Drug Product CDMO
4
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
5